Jagsonpal Pharmaceuticals Limited on Monday said it will acquire an 85% equity stake in Aequitas Healthcare Private Limited for ₹20.8 crore, marking its strategic entry into the hospital segment, according to a stock exchange filing.
“The proposed acquisition marks Jagsonpal’s strategic entry into the hospital segment and is aligned with the Company’s long-term vision of strengthening its presence in India’s growing healthcare ecosystem,” Jagsonpal Pharmaceuticals said in its exchange filing.
The acquisition will be funded through internal accruals and is expected to be completed by July 15, subject to customary closing conditions. The current promoters of Aequitas will retain the remaining 15% stake and continue to be associated with the business.
J Sagar & Associates were the legal Advisors to Jagsonpal, while Noverra Partners advised Aequitas on the transaction.
